3,3-dimethylbutan-1-ol has been researched along with Atherosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buffa, JA; Culley, MK; DiDonato, AJ; DiDonato, JA; Fu, X; Gu, X; Hazen, JE; Hazen, SL; Huang, Y; Krajcik, D; Levison, BS; Lusis, AJ; Org, E; Roberts, AB; Wang, Z; Zamanian-Daryoush, M; Zhu, W | 1 |
1 other study(ies) available for 3,3-dimethylbutan-1-ol and Atherosclerosis
| Article | Year |
|---|---|
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Choline; Diet; Feces; Foam Cells; Gastrointestinal Tract; Hexanols; Humans; Lyases; Methylamines; Mice; Mice, Inbred C57BL; Microbiota | 2015 |